Patents by Inventor Andrew Vila

Andrew Vila has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INJECTABLE IBUPROFEN FORMULATION
    Publication number: 20130245591
    Abstract: The present invention provides a pharmaceutical composition comprising an aqueous solution of an ibuprofen solubilizing agent and ibuprofen, the ibuprofen solubilizing agent being in an effective amount such that the ibuprofen in the solution remains soluble at concentrations from 100 mg/mL to 5 mg/mL without undergoing a phase transition. The invention further provides a method of treating a condition chosen from pain, inflammation, fever, and/or patent ductus arteriosis, comprising administering to a patient in need thereof an effective amount of an aqueous solution a ibuprofen solubilizing agent and ibuprofen, the ibuprofen solubilizing agent being in an effective amount such that the ibuprofen in the solution remains soluble at concentrations from 100 mg/mL to 5 mg/mL without undergoing a phase transition, as well as a method for manufacturing the composition.
    Type: Application
    Filed: March 16, 2012
    Publication date: September 19, 2013
    Applicant: Cumberland Pharmaceuticals Inc.
    Inventors: Leo Pavliv, Andrew Vila
  • Stabilized statin formulations
    Patent number: 8372877
    Abstract: The present invention is directed to statin formulations having improved solubility and/or stability and methods for the same.
    Type: Grant
    Filed: April 16, 2010
    Date of Patent: February 12, 2013
    Assignee: Cumberland Pharmaceuticals
    Inventors: Leo Pavliv, Andrew Vila
  • STABILIZED STATIN FORMULATIONS
    Publication number: 20110257240
    Abstract: The present invention is directed to statin formulations having improved solubility and/or stability and methods for the same.
    Type: Application
    Filed: April 16, 2010
    Publication date: October 20, 2011
    Applicant: Cumberland Pharmaceuticals Inc.
    Inventors: Leo Pavliv, Andrew Vila